✦ LIBER ✦

Phase 2 Study of Combined Sorafenib and Radiation Therapy in Patients With Advanced Hepatocellular Carcinoma

✍ Scribed by Chen, Shang-Wen; Lin, Li-Ching; Kuo, Yu-Cheng; Liang, Ji-An; Kuo, Chia-Chun; Chiou, Jeng-Fong

Book ID: 122272088
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 489 KB
Volume: 88
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.01.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study investigating everolimus c

Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma

✍ Finn, Richard S.; Poon, Ronnie T.P.; Yau, Thomas; Klümpen, Heinz-Josef; Chen, Li 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Phase II study of combining sorafenib wi

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma

✍ Chih-Hung Hsu; Ying-Chun Shen; Zhong-Zhe Lin; Pei-Jer Chen; Yu-Yun Shao; Yea-Hui 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Phase 1 trial of S-1 in combination with

Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

✍ Su Jin Lee, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Won Ki Kang, 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 156 KB

Concurrent Versus Sequential Sorafenib T

Concurrent Versus Sequential Sorafenib Therapy in Combination With Radiation for Hepatocellular Carcinoma: A Preclinical Study

✍ Wild, A.; Gandhi, N.; Aziz, K.A.; Chettiar, S.T.; Gajula, R.P.; Kumar, R.; Torbe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Phase I study of sorafenib in Japanese p

Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma

✍ Junji Furuse; Hiroshi Ishii; Kohei Nakachi; Eiichiro Suzuki; Satoshi Shimizu; Ke 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Phase 2 study of cetuximab in patients w

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

✍ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.